| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BALL BRYAN | Chief Technical Operations Officer and SVP, Manufacturing Operations | C/O WHITEHAWK THERAPEUTICS, INC., 2 HEADQUARTERS PLAZA, EAST BUILDING, 11T, MORRISTOWN | /s/ Stephen Rodin, as Attorney-in-Fact | 10 Mar 2026 | 0001766522 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WHWK | Common Stock | Options Exercise | +5,000 | +2.5% | 207,853 | 01 Mar 2026 | Direct | F1 | ||
| transaction | WHWK | Common Stock | Sale | $6,070 | -1,834 | -0.88% | $3.31 | 206,019 | 02 Mar 2026 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WHWK | Restricted Stock Units | Options Exercise | -5,000 | -33% | $0.000000* | 10,000 | 01 Mar 2026 | Common Stock | 5,000 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock. |
| F2 | Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. |
| F3 | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024. |
Chief Technical Operations Officer and SVP, Manufacturing Operations